France
PKvitality, founded in 2017 and based in France, is positioned at the forefront of the bio-wearable industry. With their innovative product line, K’Track, they aim to revolutionize the health and fitness wearable market. This technology uniquely analyzes key physiological markers via skin, eliminating the need for traditional blood sampling.
The company’s flagship product, the K’Track Glucose, is poised to transform the lives of diabetes patients by offering a discreet and painless continuous glucose monitoring system within a smartwatch form factor. They are also targeting fitness enthusiasts with the K’Track Athlete, a lactate monitor, evidencing their dual focus on medical and sports applications.
As of December 31, 2021, PKvitality secured a €6.00M Series A investment to further propel their mission, with backing from prominent investors such as the European Innovation Council, Beurer, Mtec Holding Gmbh, EIT Health, and various Business Angels. The company's strategic focus and disruptive technology position it well for significant impact in the health care and consumer electronics sectors. Regulatory clearance remains a key milestone for product launch and growth acceleration.
